Skip to content

What is the drug guanfacine used to treat?

5 min read

Originally developed to treat high blood pressure, the drug guanfacine has since expanded its approved uses to include attention deficit hyperactivity disorder (ADHD) in children and adolescents. This non-stimulant medication works by affecting neurotransmitters in the brain to help regulate attention, impulsivity, and emotional responses.

Quick Summary

Guanfacine is a non-stimulant medication approved to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure (hypertension). Its extended-release formulation is used for ADHD, while immediate-release tablets help manage hypertension.

Key Points

  • Dual FDA-Approved Uses: Guanfacine is used to treat two distinct conditions: attention deficit hyperactivity disorder (ADHD) and high blood pressure (hypertension).

  • ADHD Treatment (Intuniv): The extended-release formulation (Intuniv) is prescribed for ADHD in children and adolescents aged 6-17 as a non-stimulant option.

  • High Blood Pressure Treatment (Tenex): The immediate-release version (Tenex) is used to manage high blood pressure by decreasing heart rate and relaxing blood vessels.

  • Mechanism of Action: Guanfacine is an alpha-2A adrenergic receptor agonist that strengthens neural signaling in the brain's prefrontal cortex for ADHD and reduces sympathetic nerve impulses for hypertension.

  • Important Side Effects: Common side effects include drowsiness, dizziness, and dry mouth. It is critical to avoid sudden discontinuation, which can lead to rebound hypertension.

  • Comparison to Clonidine: Guanfacine is more selective for the alpha-2A receptor, generally causing less sedation and dizziness than clonidine.

  • Off-Label Uses: Clinical practice and some research support its off-label use for other conditions like anxiety disorders, Tourette syndrome, and PTSD.

In This Article

What is the drug guanfacine used to treat?

Guanfacine is a versatile prescription medication with two primary, FDA-approved uses: treating attention deficit hyperactivity disorder (ADHD) and managing high blood pressure (hypertension). The specific formulation of the drug determines which condition it is prescribed for. The extended-release form, sold under the brand name Intuniv, is used for ADHD, while the immediate-release tablet (formerly branded Tenex) is used for hypertension. Its mechanism as a centrally acting alpha-2A adrenergic receptor agonist provides therapeutic effects for both neurological and cardiovascular issues.

How Guanfacine Works

As a selective alpha-2A adrenergic receptor agonist, guanfacine functions by targeting specific receptors in both the brain and the peripheral nervous system. This action helps to regulate norepinephrine, a neurotransmitter that plays a role in alertness and focus. The drug's therapeutic effects differ depending on the target system:

  • For ADHD: Guanfacine acts primarily in the prefrontal cortex, the part of the brain responsible for executive functions like attention, impulse control, and planning. By strengthening signaling in this region, it helps to improve cognitive control and reduce symptoms of impulsivity and hyperactivity.
  • For High Blood Pressure: Guanfacine stimulates alpha-2 adrenergic receptors in the brainstem, which decreases sympathetic nerve impulses to the heart and blood vessels. This leads to a reduction in heart rate and peripheral vascular resistance, ultimately lowering blood pressure.

Guanfacine for ADHD (Intuniv)

The extended-release version of guanfacine, Intuniv, is FDA-approved for treating ADHD in children and adolescents aged 6 to 17. It is available as a once-daily tablet and can be used as a monotherapy or alongside stimulant medications. One of its key benefits is that it is a non-stimulant, making it a suitable alternative for individuals who experience adverse side effects from stimulants, such as anxiety or insomnia. The gradual release of the medication over 24 hours provides a steady, consistent therapeutic effect.

How Guanfacine Helps with ADHD

Unlike stimulants that increase neurotransmitter levels more rapidly, guanfacine offers a gentler, more stabilizing effect on brain activity. For children and adolescents with ADHD, this can result in several improvements:

  • Improved focus and attention: By strengthening neural signaling in the prefrontal cortex, guanfacine enhances the brain's ability to regulate focus and minimize distraction.
  • Better impulse control: The medication helps to strengthen the brain's "top-down" control over impulsive behavior, reducing acting-out behaviors.
  • Regulation of emotional responses: Guanfacine can help manage emotional dysregulation, irritability, and aggression, which often co-occur with ADHD.
  • Sleep improvement: Its calming effects can also aid those with ADHD who have difficulty falling or staying asleep, an effect that is especially noticeable in the first few weeks of treatment.

Guanfacine for High Blood Pressure (Tenex)

The immediate-release formulation of guanfacine, Tenex, is used to treat hypertension. It is typically taken once daily, usually at bedtime to minimize the impact of drowsiness. While not a first-line treatment, it can be used alone or in combination with other blood pressure medications. It works by reducing the heart rate and relaxing blood vessels, allowing blood to flow more easily. Managing high blood pressure is crucial for long-term health, and this medication helps reduce the risk of more serious complications like stroke, heart failure, and kidney damage.

Potential Side Effects and Precautions

Both formulations of guanfacine can cause side effects, though most are mild and tend to diminish over time as the body adjusts. Common side effects include:

  • Dry mouth
  • Dizziness or lightheadedness
  • Drowsiness or sedation
  • Fatigue or weakness
  • Nausea and stomach pain
  • Constipation
  • Decreased appetite

More serious, but less common, side effects include a slow heart rate and fainting, which can be linked to a sudden drop in blood pressure. It is important to rise slowly when getting up from a seated or lying position to prevent orthostatic hypotension. Abrupt discontinuation of guanfacine should be avoided, as it can cause rebound hypertension and other withdrawal symptoms like anxiety and nervousness. It is crucial to taper the dose under a doctor's supervision if stopping the medication.

Certain medical conditions or medications can make the use of guanfacine riskier. Patients with a history of heart conditions, low blood pressure, liver or kidney disease should use caution and inform their healthcare provider. Guanfacine can also interact with other medications, including certain blood pressure drugs, depressants, and CYP3A4 inhibitors/inducers.

Comparison: Guanfacine vs. Clonidine

Guanfacine is an alpha-2A adrenergic receptor agonist, a class of medication that also includes clonidine (brand name Kapvay for ADHD). While they share a similar mechanism of action, their properties differ in some key aspects, as highlighted in the following table.

Feature Guanfacine (Intuniv ER) Clonidine (Kapvay ER)
Mechanism of Action More selective for the alpha-2A receptor subtype, acting primarily in the prefrontal cortex. Less selective, with broader action on alpha-2 receptor subtypes.
Sedation Generally less sedating, making it preferable for many patients needing daytime alertness. Tends to be more sedating, often used for patients with co-occurring sleep issues.
Half-Life Longer half-life, allowing for once-daily dosing. Shorter half-life; extended-release versions are dosed once or twice daily.
Hypotension Risk Less potential for causing significant drops in blood pressure compared to clonidine. Higher risk of causing hypotension and dizziness.
Off-Label Uses May be used for PTSD, tic disorders, and anxiety, with emerging research for other conditions. Also used for tics and anxiety, often considered when sedation is beneficial.
FDA Approval (ADHD) Approved for ADHD in children and adolescents aged 6-17. Approved for ADHD in children and adolescents aged 6-17.

Conclusion

Guanfacine is a valuable medication in pharmacology, with distinct uses for both ADHD and high blood pressure. Its specific mechanism of action allows it to enhance cognitive function for those with ADHD while also effectively lowering blood pressure. The extended-release formulation (Intuniv) is a gentle yet effective non-stimulant option for ADHD, particularly for those who do not tolerate stimulant side effects. In contrast, the immediate-release version (Tenex) is a reliable treatment for hypertension. While generally well-tolerated, potential side effects and precautions related to blood pressure and sedation must be monitored closely by a healthcare professional. For individuals and clinicians considering this medication, understanding its dual uses, distinct formulations, and comparison to similar drugs like clonidine is essential for making an informed treatment decision.

Learn more about guanfacine, its uses, and potential side effects from the National Alliance on Mental Illness (NAMI).

Frequently Asked Questions

Intuniv is the brand name for the extended-release version of guanfacine, which is used for ADHD. Tenex was the brand name for the immediate-release version, used for high blood pressure. They have different formulations and therapeutic purposes.

No, guanfacine is a non-stimulant medication used for ADHD. This makes it a useful alternative for patients who cannot tolerate the side effects of stimulant medications.

Guanfacine stimulates alpha-2 adrenergic receptors in the brain, which reduces nerve impulses that tighten blood vessels. This action results in relaxed blood vessels and a decreased heart rate, thereby lowering blood pressure.

It may take 1 to 2 weeks to start noticing benefits from extended-release guanfacine (Intuniv) and up to 4 to 8 weeks to feel the full effects.

Common side effects include drowsiness, dizziness, dry mouth, headache, fatigue, stomach pain, and constipation.

Abruptly stopping guanfacine can cause a rebound effect, leading to a rapid increase in blood pressure, nervousness, and anxiety. A doctor should supervise the tapering of the dosage to prevent these effects.

While the extended-release formulation (Intuniv) is FDA-approved for ADHD in children and adolescents, it is sometimes used off-label to treat adults with ADHD. However, its effectiveness in older adolescents (13-17) may be questionable, and adult usage should be determined by a doctor.

Guanfacine is sometimes used off-label to treat tics associated with Tourette syndrome, especially when stimulant medications are also being used.

Guanfacine is more selective for the alpha-2A receptor and is generally less sedating than clonidine. This may make it a preferable option for some patients, particularly for daytime use.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.